CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 315

Industry reads hand-picked by our editors

Aug 26, 2016

Reuters
Lung cancer doctors eye Merck's Keytruda over Bristol's Opdivo
USA Today
Mylan isn't alone: 11 drugmakers with off-the-charts pricing power
The Hill
FDA: All blood donations should be tested for Zika
Wall Street Journal
Sen. Joe Manchin, Father of Mylan’s CEO, Airs ‘Concerns’ About Drug Costs

Aug 25, 2016

Stat
When DNA and medical tests disagree about breast cancer risk, which to believe?
Reuters
Novartis announces positive phase III results for MS drug siponimod
The Street
Hillary Clinton blasts drug prices, biotech stocks plunge
BloombergGadfly
Pfizer: Let's stay together

Aug 24, 2016

Forbes
Life after Martin Shkreli—A conversation with Turing Pharmaceutical's R&D head
MIT Technology Review
35 innovators under 35
Stat
Experimental cancer therapy holds great promise—but at great cost
Xconomy
In wake of infamous biotech party, 20 women join new exec training

Aug 23, 2016

pharma phorum
EU approves Gilead’s Truvada for HIV prevention
STAT
The science of mass hysteria: When we face uncertainty, our minds crave explanations
The Wall Street Journal
With Moderate Drinking Under Fire, Alcohol Companies Go on Offensive

Aug 22, 2016

STAT
26 overdoses in just hours: Inside a community on the front lines of the opioid epidemic
MM&M
Healthcare agencies not immune to gender bias, parity issues
Xconomy
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples

Aug 19, 2016

Ad Age
McDonald's Pulls Happy Meal Fitness Bands Due to Skin Irritation
In The Pipeline
Three Diseases at Once?
STAT
HIPAA turns 20: Five things you should know about your medical records

Aug 18, 2016

STAT
Do incentives nudge physicians to prescribe opioids for pain?
MM&M
Lobbyists create off-label principles following FDA lawsuits
mobihealthnews
AstraZeneca plans new connected inhaler trial to improve medication adherence in COPD patients

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Industry Report
CGT Commercialization: Tackling Barriers to Market Success Custom content for Cencora
Playbook
Centralized Clinical Trial Recruitment: A Strategic Plan Custom content for WCG
Trendline
Inside the growing treatment market for rare diseases Supported by Advanced Clinical

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Understanding Publication Impact and Engagement with Data and AI-Driven Solutions Webinar - on demand • Provided by Altmetric
Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID
Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance Webinar - on demand • Provided by Certara

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.